Last week, the FDA announced approval of the Medtronic 670G, which is considered by some to be the first pump system worthy of the label of artificial pancreas. However, the 670G still requires a fair amount of user input, and there are other artificial pancreas pump systems in clinical trials that may offer the promise of even more automation of blood sugar control.
How did the 670G and the iLet Perform in Trials?
Posted in Artificial Pancreas